Serine protease inhibitor AEBSF reduces dengue virus infection via decreased cholesterol synthesis (Q92452559)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31386864%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

title

Serine protease inhibitor AEBSF reduces dengue virus infection via decreased cholesterol synthesis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31386864%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31386864%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31386864%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

Pucharee Songprakhon

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31386864%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

Atthapan Morchang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31386864%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

Chatchawan Srisawat

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31386864%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

Sansanee Noisakran

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31386864%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

Pa-Thai Yenchitosomanus

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31386864%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

Thawornchai Limjindaporn

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31386864%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

publication date

3 August 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31386864%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31386864%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

volume

271

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31386864%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

page(s)

197672

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31386864%20AND%20SRC:MED&resulttype=core&format=json

Proteases and protease inhibitors in infectious diseases

29 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2019.197672

Inhibition of lung serine proteases in mice: a potentially new approach to control influenza infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2019.197672

Molecular aspects of Dengue virus replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2019.197672

Aminoethyl benzenesulfonyl fluoride and its hexapeptide (Ac-VFRSLK) conjugate are both in vitro inhibitors of subtilisin kexin isozyme-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2019.197672

The global distribution and burden of dengue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2019.197672

A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2019.197672

The anti‑dengue virus properties of statins may be associated with alterations in the cellular antiviral profile expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2019.197672

Evaluation of two inhibitors of invasion: LY311727 [3-(3-acetamide-1-benzyl-2-ethyl-indolyl-5-oxy)propane phosphonic acid] and AEBSF [4-(2-aminoethyl)-benzenesulphonyl fluoride] in acute murine toxoplasmosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2019.197672

Infection of human cells by dengue virus is modulated by different cell types and viral strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2019.197672

Exploitation of cellular pathways by Dengue virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2019.197672

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2019.197672

Dengue virus-induced autophagy regulates lipid metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2019.197672

Human Subtilisin Kexin Isozyme-1 (SKI-1)/Site-1 Protease (S1P) regulates cytoplasmic lipid droplet abundance: A potential target for indirect-acting anti-dengue virus agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2019.197672

Flavivirus modulation of cellular metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2019.197672

Dengue Virus Activates the AMP Kinase-mTOR Axis To Stimulate a Proviral Lipophagy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2019.197672

Dengue virus infection: Epidemiology, pathogenesis, clinical presentation, diagnosis, and prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2019.197672

Activity of recombinant dengue 2 virus NS3 protease in the presence of a truncated NS2B co-factor, small peptide substrates, and inhibitors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2019.197672

Ten years of dengue drug discovery: progress and prospects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2019.197672

Interaction of dengue virus envelope protein with endoplasmic reticulum-resident chaperones facilitates dengue virus production.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2019.197672

Multifunctional serine protease inhibitor-coated water-soluble gold nanoparticles as a novel targeted approach for the treatment of inflammatory skin diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2019.197672

Statins reduce dengue virus production via decreased virion assembly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2019.197672

Lovastatin delays infection and increases survival rates in AG129 mice infected with dengue virus serotype 2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2019.197672

4-(2-Aminoethyl)benzenesulfonyl fluoride attenuates tumor-necrosis-factor-alpha-induced blood-brain barrier opening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2019.197672

Molecular basis of human immunodeficiency virus drug resistance: an update.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2019.197672

Dengue virus NS3 serine protease. Crystal structure and insights into interaction of the active site with substrates by molecular modeling and structural analysis of mutational effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2019.197672

A serine protease inhibitor prevents endoplasmic reticulum stress-induced cleavage but not transport of the membrane-bound transcription factor ATF6.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2019.197672

Protease inhibitors as antiviral agents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2019.197672

Human glucose-regulated protein 78 modulates intracellular production and secretion of nonstructural protein 1 of dengue virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2019.197672

Emerging drugs for hepatitis C

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2019.197672

DENV up-regulates the HMG-CoA reductase activity through the impairment of AMPK phosphorylation: A potential antiviral target.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2019.197672

The increase in cholesterol levels at early stages after dengue virus infection correlates with an augment in LDL particle uptake and HMG-CoA reductase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2019.197672

Site-1 protease cleavage site is important for the ER stress-induced activation of membrane-associated transcription factor bZIP28 in Arabidopsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2019.197672

Hepatitis C virus hijacks host lipid metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2019.197672

Suppressive Effects of the Site 1 Protease (S1P) Inhibitor, PF-429242, on Dengue Virus Propagation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2019.197672

Respiratory syncytial virus (RSV) entry is inhibited by serine protease inhibitor AEBSF when present during an early stage of infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2019.197672

Targeting host lipid synthesis and metabolism to inhibit dengue and hepatitis C viruses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2019.197672

Effect of protease inhibitors on yield of HSV-1-based viral vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2019.197672

Novel dengue virus NS2B/NS3 protease inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2019.197672

Novel Dengue Virus-Specific NS2B/NS3 Protease Inhibitor, BP2109, Discovered by a High-Throughput Screening Assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2019.197672

ER stress induces cleavage of membrane-bound ATF6 by the same proteases that process SREBPs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2019.197672

Dengue serotype-specific differences in clinical manifestation, laboratory parameters and risk of severe disease in adults, singapore

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2019.197672

10.1016/J.VIRUSRES.2019.197672

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31386864%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31386864%20AND%20SRC:MED&resulttype=core&format=json